UK Medicines Information
Paclitaxel albumin-bound nanoparticles (Abraxane®) 5 mg/ml powder for suspension for infusion
Information type:
Drug best practice guidance
Source:
All Wales Medicines Strategy Group
Specialities:
Cancers
Summary
Paclitaxel albumin bound nanoparticles (Abraxane®) is recommended as an option for use within NHS Wales in combination with gemcitabine for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas.
UKMi comment
The appraisal report and clinical expert summary are available via the links below.
Related links:
Secretariat Appraisal Report
Clinical Expert Summary